Medication-Assisted Treatment (MAT) and Medications for Opioid Use Disorder (MOUD) have focused heavily on methadone and buprenorphine. This post explores why naltrexone, a non-opioid antagonist, may be better understood as “Medication-Assisted Prevention” and why elevating its role could be critical to reducing opioid overdose deaths.

A new approach to addiction care proposes Safe Prevention Clinics, leveraging pharmacies and medications like naltrexone to move beyond harm reduction toward true prevention.

Nitazenes, a new class of highly potent synthetic opioids, are emerging in Missouri’s drug supply and raising serious concerns about overdose risk. As the opioid crisis continues to evolve, current treatment and prevention strategies may not be enough to address what comes next.